Elena Violari, MD

Dr. Violari is a board-certified interventional radiologist. She obtained her medical degree from the University of Athens, in Greece. She then completed a post-doctoral research fellowship in interventional oncology at Memorial Sloan Kettering Cancer Center in New York City followed by a general surgery internship at the University of Maryland. She completed her residency training in Diagnostic Radiology at the University of Connecticut where she served as chief resident. She then further subspecialized in Vascular and Interventional Radiology at the Baptist Health, Miami Cardiac & Vascular Institute. Subsequently, she completed a second fellowship in Pediatric Radiology with a focus on pediatric interventional radiology at Stanford University.

Dr. Violari has a broad range of clinical interests and expertise in both adult and pediatric interventions, including interventional oncology (locoregional therapies for cancer such as radioembolization, chemoembolization and ablations), women's health (minimally invasive treatment options for uterine fibroids and pelvic congestion syndrome), portal hypertension, vascular malformations and deep venous disease. Dr. Violari has a passion for medical education and is a strong patient advocate.

Research Publications:
• Abdominal Vascular Evaluation. Aly A., Burt R., Violari E.G., Pena C., Bryce Y. Tech Vasc Interv Radiol (TVIR). December 2022

• Endovascular Treatment of Infra-Inguinal Peripheral Arterial Disease (PAD): Update on Stent Technology. Violari E.G., Payomo A., Schiro B.J. Powell A., Gandhi R.T., Pena C.S.
Tech Vasc Interv Radiol (TVIR). September 2022

• Multidisciplinary management of newly diagnosed pediatric large cell neuroendocrine carcinoma of the lung causing hemoptysis. Marquez, C.P., Violari E.G., Sodj Q., Jiang A.L., Donaldson S.S., Josephs S., and Hiniker S.M., Pediatric Blood Cancer, June 2021

• Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism. Violari E.G., Arici M.H, Singh C.K, Georgiades C.S, Tendler B.R, Shichman S.J, Malchoff C.D Endocrinology, Diabetes & Metabolism, March 2019.

• Fluoro-deoxyglucose PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation. Cornelis F, Sotirchos V, Violari E.G., Sofocleous CT, Schoder H, Durack J, Siegelbaum R, Maybody, M, Humm J, Solomon S. J Nucl Med. (JNM) July 2016.

• Radioembolization as a Salvage Therapy for Heavily Pretreated Patients with Colorectal Cancer Liver Metastases: Factors that Factors that affect outcomes Sofocleous CT, Violari E.G., Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, Petre EN, Brody LA, Alago W, Do RK, D' Angelica MI, Osborne JR, Segal NH, Carrasquillo JA, Kemeny NE. . Clinical Colorectal Cancer, April 2015

• Successful Control of Liver Metastases from Pancreatic Solid Pseudopapillary Neoplasm (SPN) Using Hepatic Arterial Embolization. Violari E.G., Brody L.A, Covey A.M, Erinjeri J.P, Getrajdman G.I, Sofocleous C.T, Reidy D.L, Jarnagin, W.R, Brown K.T. Cardiovascular Interventional Radiology (CVIR), April 2015.

• Microwave ablation (MWA) for the treatment of a solitary chemorefractory testicular cancer liver metastasis. Violari E.G, Petre E.N., Erinjeri J.P., Brown K.T., Solomon S.B., D'Angelica M.I., Feldman D.R., Sofocleous C.T. Cardiovascular Interventional Radiology (CVIR), April 2015